Intervention not reported
Severity diarrhoea ‐ not reported · patients with HIV exposure (children)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Upper Respiratory Tract Infection number of episodes per number of months · patients with HIV exposure (children)
The intervention showed no clear difference in upper Respiratory Tract Infection number of episodes per number of… (low certainty).
1 finding from 1 review
Intervention not reported
Mortality, all‐cause · patients with HIV infection or exposure
The intervention showed no clear difference in mortality, all‐cause (low certainty).
1 finding from 1 review
Intervention not reported
Mortality, diarrhea‐specific · patients with HIV infection or exposure
The intervention showed no clear difference in mortality, diarrhea‐specific (low certainty).
1 finding from 1 review
Intervention not reported
Visits for watery diarrhoea number of visits with diagnosis watery diarrhoea/all visits · patients with HIV infection or exposure
The intervention may leads to lower visits for watery diarrhoea number of visits with diagnosis watery… (low certainty).
1 finding from 1 review
Intervention not reported
Pneumonia number of visits with diagnosis pneumonia/all visits · patients with HIV infection or exposure
The intervention showed no clear difference in pneumonia number of visits with diagnosis pneumonia/all visits (low certainty).
1 finding from 1 review
Intervention not reported
Upper Respiratory Infections number of visits with diagnosis URI/all visits · patients with HIV infection or exposure
The intervention showed no clear difference in upper Respiratory Infections number of visits with diagnosis URI/all… (low certainty).
1 finding from 1 review
Intervention not reported
Severe adverse events ‐ not reported · patients with HIV infection or exposure
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Anthropometric outcomes ‐ not reported · patients with HIV infection or exposure
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Mortality, all‐cause · patients with HIV infection or exposure
The intervention probably leads to lower mortality, all‐cause (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality, all cause3 · patients with HIV infection or exposure
1 finding from 1 review
Intervention not reported
Mortality, diarrhoea‐specific hospital deaths due to diarrhoea and/or dehydration · patients with HIV infection or exposure
The intervention showed no clear difference in mortality, diarrhoea‐specific hospital deaths due to diarrhoea… (low certainty).
1 finding from 1 review
Intervention not reported
Ever diarrhea history · patients with HIV infection or exposure
It is very uncertain whether the intervention changes ever diarrhea history (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events Grade 3 or 4 adverse event · patients with HIV infection or exposure
The intervention showed no clear difference in adverse events Grade 3 or 4 adverse event (low certainty).
1 finding from 1 review
Intervention not reported
Hospitalisations due to diarrhoea · patients with HIV infection or exposure
The intervention showed no clear difference in hospitalisations due to diarrhoea (low certainty).
1 finding from 1 review
Intervention not reported
Respiratory infections hospital admission for pneumonia/empyema · patients with HIV infection or exposure
The intervention showed no clear difference in respiratory infections hospital admission for pneumonia/empyema (low certainty).
1 finding from 1 review
Intervention not reported
Mortality, all‐cause · patients with HIV exposure (children)
1 finding from 1 review
Intervention not reported
Mortality, diarrhoea‐specific ‐ not reported · patients with HIV exposure (children)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection with SARS‐CoV‐2 within 6 months · SARS‐CoV‐2 uninfected people without defined exposure, or with potential exposure to SARS‐CoV‐2
Tixagevimab/cilgavimab probably leads to lower infection with SARS‐CoV‐2 within 6 months compared with placebo (moderate certainty).
1 finding from 1 review
Infection with SARS‐CoV‐2 within 6 months · SARS‐CoV‐2 uninfected people without defined exposure, or with potential exposure to SARS‐CoV‐2
Casirivimab/imdevimab may leads to lower infection with SARS‐CoV‐2 within 6 monthsa compared with placebo (low certainty).
1 finding from 1 review